A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This Senate resolution expresses the sense of the Senate that policies regarding mifepristone, a medication used in abortion care, should be based on over 25 years of scientific evidence demonstrating its safety and effectiveness. It calls for equitable, transparent, and evidence-based regulations for access to this medication, acknowledging the FDA’s rigorous reviews and modifications to the medication’s REMS program. The resolution also highlights the disproportionate impact of abortion restrictions on marginalized communities.
Key provisions
- The Senate believes mifepristone’s safety and effectiveness should be respected based on extensive scientific evidence.
- FDA policies regarding mifepristone should be grounded in peer-reviewed, evidence-based science.
- The FDA has conducted multiple scientific reviews of mifepristone, consistently finding it safe and effective.
- The resolution emphasizes the need for equitable access to medication abortion care.
- It calls for preserving the ability to prescribe mifepristone through telemedicine and dispense it by mail or at pharmacies.
- The resolution recognizes the impact of abortion restrictions on marginalized communities.
- It references the FDA’s modification to the Mifepristone REMS to reduce burdens on patient access.
- It acknowledges the World Health Organization’s recognition of mifepristone as an essential medicine.
Who is affected
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
47 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours